-
Je něco špatně v tomto záznamu ?
High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice
E. Dolezelova, ICI. Sa, A. Prasnicka, M. Hroch, R. Hyspler, A. Ticha, H. Lastuvkova, J. Cermanova, M. Pericacho, J. Visek, M. Lasticova, S. Micuda, P. Nachtigal,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Grantová podpora
NV17-31754A
MZ0
CEP - Centrální evidence projektů
- MeSH
- cholesterol krev metabolismus MeSH
- endoglin krev fyziologie MeSH
- feces MeSH
- homeostáza * MeSH
- játra metabolismus MeSH
- LDL-receptory metabolismus MeSH
- myši transgenní MeSH
- myši MeSH
- oxidační stres MeSH
- přenašeče organických aniontů závislé na sodíku metabolismus MeSH
- protein SREBP2 metabolismus MeSH
- symportéry metabolismus MeSH
- upregulace MeSH
- zánět krev MeSH
- žlučové kyseliny a soli krev metabolismus MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: Increased plasma soluble endoglin concentrations (sEng) are frequently detected in metabolic disorders accompanied with hypercholesterolemia in serum, but effect of sEng on the cholesterol biochemistry is unknown. Cholesterol and bile acids (BA) are important products of liver metabolism with numerous functions within the organism. Turnover of these substances requires precise regulation due to potential toxicities during their cumulation. In this study, we hypothesized that high sEng levels affect cholesterol homeostasis and BA turnover in mice liver. MAIN METHODS: Nine-month-old transgenic male mice overexpressing human sEng and wild-type mice underwent plasma, bile, stool, and organ samples analysis by analytical, qRT-PCT and Western blot methods. KEY FINDINGS: sEng mice demonstrated decreased plasma total and LDL cholesterol concentrations due to upregulation of hepatic Sr-b1 and Ldlr receptors, increased liver cholesterol content, and increased Abcg8-mediated cholesterol efflux into bile. sEng also increased conversion of cholesterol into bile acids (BA) via upregulation of Cyp7a1 and increased Mdr1 expression. Plasma concentrations of BA were increased in sEng mice due to their enhanced reabsorption via ileum. Increased hepatic disposition of BA led to their increased biliary excretion coupled with choleretic activity. SIGNIFICANCE: For the first time, we have shown that high sEng plasma levels affect cholesterol and BA homeostasis on the basis of complex liver and intestinal effects. The significance of these findings for pathophysiology of diseases associated with increased sEng concentrations remains to be elucidated in prospective studies.
Centrum for Research and Development University Hospital Hradec Kralove Czech Republic
Department of Biochemistry Faculty of Medicine in Hradec Kralove Charles University Czech Republic
Department of Pharmacology Faculty of Medicine in Hradec Kralove Charles University Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044668
- 003
- CZ-PrNML
- 005
- 20200115125257.0
- 007
- ta
- 008
- 200109s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.lfs.2019.116643 $2 doi
- 035 __
- $a (PubMed)31299237
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Dolezelova, Eva $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic.
- 245 10
- $a High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice / $c E. Dolezelova, ICI. Sa, A. Prasnicka, M. Hroch, R. Hyspler, A. Ticha, H. Lastuvkova, J. Cermanova, M. Pericacho, J. Visek, M. Lasticova, S. Micuda, P. Nachtigal,
- 520 9_
- $a AIMS: Increased plasma soluble endoglin concentrations (sEng) are frequently detected in metabolic disorders accompanied with hypercholesterolemia in serum, but effect of sEng on the cholesterol biochemistry is unknown. Cholesterol and bile acids (BA) are important products of liver metabolism with numerous functions within the organism. Turnover of these substances requires precise regulation due to potential toxicities during their cumulation. In this study, we hypothesized that high sEng levels affect cholesterol homeostasis and BA turnover in mice liver. MAIN METHODS: Nine-month-old transgenic male mice overexpressing human sEng and wild-type mice underwent plasma, bile, stool, and organ samples analysis by analytical, qRT-PCT and Western blot methods. KEY FINDINGS: sEng mice demonstrated decreased plasma total and LDL cholesterol concentrations due to upregulation of hepatic Sr-b1 and Ldlr receptors, increased liver cholesterol content, and increased Abcg8-mediated cholesterol efflux into bile. sEng also increased conversion of cholesterol into bile acids (BA) via upregulation of Cyp7a1 and increased Mdr1 expression. Plasma concentrations of BA were increased in sEng mice due to their enhanced reabsorption via ileum. Increased hepatic disposition of BA led to their increased biliary excretion coupled with choleretic activity. SIGNIFICANCE: For the first time, we have shown that high sEng plasma levels affect cholesterol and BA homeostasis on the basis of complex liver and intestinal effects. The significance of these findings for pathophysiology of diseases associated with increased sEng concentrations remains to be elucidated in prospective studies.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a žlučové kyseliny a soli $x krev $x metabolismus $7 D001647
- 650 _2
- $a cholesterol $x krev $x metabolismus $7 D002784
- 650 _2
- $a endoglin $x krev $x fyziologie $7 D000071063
- 650 _2
- $a feces $7 D005243
- 650 12
- $a homeostáza $7 D006706
- 650 _2
- $a zánět $x krev $7 D007249
- 650 _2
- $a játra $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši transgenní $7 D008822
- 650 _2
- $a přenašeče organických aniontů závislé na sodíku $x metabolismus $7 D029363
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a LDL-receptory $x metabolismus $7 D011973
- 650 _2
- $a protein SREBP2 $x metabolismus $7 D051782
- 650 _2
- $a symportéry $x metabolismus $7 D027981
- 650 _2
- $a upregulace $7 D015854
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sa, Ivone Cristina Igreja $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic.
- 700 1_
- $a Prasnicka, Alena $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic.
- 700 1_
- $a Hroch, Milos $u Department of Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Czech Republic.
- 700 1_
- $a Hyspler, Radomir $u Centrum for Research and Development, University Hospital, Hradec Kralove, Czech Republic.
- 700 1_
- $a Ticha, Alena $u Centrum for Research and Development, University Hospital, Hradec Kralove, Czech Republic.
- 700 1_
- $a Lastuvkova, Hana $u Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Charles University, Czech Republic.
- 700 1_
- $a Cermanova, Jolana $u Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Charles University, Czech Republic.
- 700 1_
- $a Pericacho, Miguel $u Biomedical Research Institute of Salamanca and Renal and Cardiovascular Physiopathology Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain.
- 700 1_
- $a Visek, Jakub $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital, Hradec Kralove, Czech Republic.
- 700 1_
- $a Lasticova, Martina $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital, Hradec Kralove, Czech Republic.
- 700 1_
- $a Micuda, Stanislav $u Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Charles University, Czech Republic. Electronic address: micuda@lfhk.cuni.cz.
- 700 1_
- $a Nachtigal, Petr $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic. Electronic address: petr.nachtigal@faf.cuni.cz.
- 773 0_
- $w MED00003147 $t Life sciences $x 1879-0631 $g Roč. 232, č. - (2019), s. 116643
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31299237 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200115125631 $b ABA008
- 999 __
- $a ok $b bmc $g 1482937 $s 1083341
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 232 $c - $d 116643 $e 20190709 $i 1879-0631 $m Life sciences $n Life Sci $x MED00003147
- GRA __
- $a NV17-31754A $p MZ0
- LZP __
- $a Pubmed-20200109